Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Breast Cancer Research and Treatment

Topics

Engineering

Cancer Oncology

Medicine

Immunology

Internal Medicine

Show all topics

DOI

10.1007/s10549-017-4537-5

License

CC-BY

Other Formats

PDF